Desacetylmethylcolchicine in the Treatment of Myeloid Leukaemia
1956

Desacetylmethylcolchicine for Myeloid Leukaemia Treatment

Sample size: 4 publication Evidence: low

Author Information

Author(s): A. M. Jelliffe, J. E. Maciver

Primary Institution: The Middlesex Hospital, London

Hypothesis

Can desacetylmethylcolchicine effectively control chronic myeloid leukaemia?

Conclusion

Desacetylmethylcolchicine can control chronic myeloid leukaemia in some patients, but it has notable side effects.

Supporting Evidence

  • One patient showed a marked fall in white cell count and a rise in hemoglobin after treatment.
  • Another patient did not respond to desacetylmethylcolchicine or any treatment and died.
  • Side effects included severe hair loss, which may be reversible.

Takeaway

This study looked at a drug called desacetylmethylcolchicine to see if it helps people with a type of blood cancer called myeloid leukaemia. It worked for some people but not for everyone, and it can make you lose your hair.

Methodology

The study involved treating four patients with chronic myeloid leukaemia using desacetylmethylcolchicine and observing their responses.

Limitations

The study had a very small sample size of only four patients.

Participant Demographics

Patients included two men and two women aged between 30 and 60.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication